PeopleBio, Inc. (KOSDAQ:304840)
South Korea · Delayed Price · Currency is KRW 777.00
+27.00 (3.60%)
At close: Apr 2, 2026
PeopleBio Market Cap
PeopleBio has a market cap or net worth of 17.8 billion as of April 2, 2026. Its market cap has decreased by -68.02% in one year.
Market Cap
17.80B
Enterprise Value
26.13B
Revenue
3.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
777.00
Market Cap Chart
Since October 19, 2020, PeopleBio's market cap has decreased from 127.63B to 17.80B, a decrease of -86.05%. That is a compound annual growth rate of -30.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 16.45B | -27.32% |
| Dec 30, 2025 | 22.63B | -64.95% |
| Dec 30, 2024 | 64.57B | -0.15% |
| Dec 28, 2023 | 64.67B | -65.14% |
| Dec 29, 2022 | 185.49B | 1.48% |
| Dec 30, 2021 | 182.78B | -36.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 482.30B |
| 3billion | 395.43B |
| GENINUS | 182.79B |
| HLB Panagene | 112.09B |
| Cytogen | 107.27B |
| Green Cross Medical Science | 81.31B |
| Protia | 56.79B |
| Seoulin Bioscience | 53.58B |